This study demonstrates important differences in distant metastatic behavior and overall survival between breast cancer subtypes, as defined by HR/HER2 status, and contributes to an expanding knowledge of prognostic markers in stage IV IBC. Here, ERBB2 is linked to inflammatory breast carcinoma.